Kidney Function Tests Market size is anticipated to grow significantly from 2022 to 2028. The percentage of people being diagnosed with chronic diseases, such as diabetes, high blood pressure, cardiovascular disorders, and Chronic Kidney Disease (CKD) is growing at a notable rate in many regions across the globe. According to the Centers for Disease Control and Prevention (CDC), more than 37 million people are estimated to be suffering from CKD.
One of the major factors contributing to the rise in these ailments is the drastic changes in the lifestyle of the people. An increasing percentage of the population are becoming dependent on unhealthy foods, such as processed and pre-cooked foods, which can have detrimental effects on their health, thereby boosting the demand for kidney function tests.
The percentage of the elderly population in regions like Europe is steadily increasing every year. According to the National Kidney Foundation, more than 50% of individuals aged over 75 years is predicted to be diagnosed with some form of kidney disorder. Since the immunity system of the geriatric population is weak, the chances of being affected by kidney diseases, diabetes, and cardiovascular ailments are high, augmenting the adoption of kidney diagnostic tests.
Dipsticks are likely to capture a significant share of kidney function tests market as chronic diseases, such as CKD, high blood pressure, and diabetes are on the rise in several regions. A patient’s urine can reveal a lot of information about their health, which will increase the use of dipsticks.
The product has a thin plastic strip consisting of chemicals that showcase different colors after coming in contact with urine. Healthcare professionals can find out about their patient’s kidney health by observing the changes in the color of the dipstick. The product can also greatly help doctors in prescribing the best treatment options to patients to help them combat their condition.
The demand for urine tests is poised to foster in the coming years. Urine tests are important as they can detect a wide range of chemicals and proteins that change the urine’s color and clarity. It can give medical experts a preliminary insight into the functioning of kidneys, which may drive the use of these tests.
Research laboratories and institutes will gain traction among end-users as medical scientists can undertake a deeper analysis of the specimens collected from hospitals to know about any underlying medical condition. As a part of kidney function testing, urine and blood samples taken at hospitals are sent to research laboratories to find out the level of toxins, such as creatinine, uric acid, and urea.
Since the specimens are collected at regular time intervals, it can help the researchers in discovering vital changes in kidney functions, which will amplify the preference for research labs and institutes among end-users.
The U.S. is expected to occupy a sizeable share of kidney function tests market as the cases of cardiovascular ailments, diabetes, and kidney disorders are rising in the country. As per the Centers for Disease Control and Prevention (CDC), 9 out of 10 adults are suffering from undiagnosed CKD, while 38% of the population aged 65 years and above had been diagnosed with CKD. Moreover, according to the U.S. renal data system 2020 annual data report, around 786,000 citizens in the U.S. were suffering from End Stage Kidney Disease (ESKD). The government is boosting its investments in the development of the healthcare sector and is encouraging organizations to develop advanced technologies that can fasten the diagnosis process and offer effective treatment options to patients, which will bolster the use of advanced kidney function tests.
Major companies that are engaged in the development of innovative kidney function tests across the world include, Acon Laboratories, Roche, Siemens, Opti Medicals, Elektronika, Beckman Coulter (Danaher), Arkray, Urit Medicals, Nova Biomedical, and Abbott Laboratories, among many others.
The number of mergers, partnership, and acquisition deals are increasing among organizations to extend their customer base, global presence, and diversify their product and service portfolios. In June 2021, Nova Biomedical opened its sales, service, and distribution office in ‘s-Hertogenbosch, Netherlands. The subsidiary is slated to provide sales and other services of the organization’s biotechnology and clinical products to its customers in the Benelux region.
While the COVID-19 pandemic posed a major threat to people suffering from CKD as they have a weak immunity system, the demand for kidney function tests remained positive as people who were undergoing dialysis were advised to continue with the treatment. A major reason behind this is that patients diagnosed with kidney disorders are at a higher risk of contracting the virus, which made it all the more compulsory for them to get their regular checkups and dialysis done with the help of kidney function tests.
Market, by Product
Market, by Test type
Market, by End-use
The above information is provided for the following regions and countries: